Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Vaccines and Molecular Therapeutics

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1525388

This article is part of the Research TopicUnderstanding Immunity Against Tick- and Mosquito-Borne Viruses to Develop Effective Vaccines and TherapeuticsView all 6 articles

Study of the influence of population immunity to tick-borne encephalitis virus on the characteristics of the epidemic process in Russia

Provisionally accepted
Temur  Khusenboevich MuminovTemur Khusenboevich Muminov1Vladimir  Alexeevich GushchinVladimir Alexeevich Gushchin1,2,3*Denis  A KleymenovDenis A Kleymenov1Artem  P TkachukArtem P Tkachuk1,4Viktor  A ManuilovViktor A Manuilov1,5Andrei  SiniavinAndrei Siniavin1,6Daria  A OgarkovaDaria A Ogarkova1Nadya  KuznetsovaNadya Kuznetsova1Vladimir  Igorevich ZlobinVladimir Igorevich Zlobin1Alexander  Leonidovich GintsburgAlexander Leonidovich Gintsburg1,7
  • 1N.F.Gamaleya Scientific Research Institute of Epidemiology and Microbiology, Russian Academy of Medical Sciences, Moscow, Russia
  • 2Department of Medical Genetics, I.M. Sechenov First Moscow State Medical University, Moscow, Russia
  • 3Department of Virology, Faculty of Biology, Lomonosov Moscow State University, Moscow, Moscow Oblast, Russia
  • 4Federal State Budgetary Institution, National Medical Research Center for Phthisiopulmonology and Infectious Diseases, Ministry of Health of the Russian Federation, Moscow, Moscow Oblast, Russia
  • 5Department of Natural Sciences, Novosibirsk State University, Novosibirsk, Novosibirsk Oblast, Russia
  • 6Department of Molecular Neuroimmune Signaling, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia
  • 7Department of Infectiology, I. M. Sechenov First Moscow State Medical University, Moscow, Russia

The final, formatted version of the article will be published soon.

Background: Tick-borne encephalitis (TBE) is a significant public health challenge in Russia.Vaccination is one of the most effective measures to control TBE. The aim of our study was to assess the state of anti-TBE virus population immunity, including artificial post-vaccine and natural post-infection immunity, in the context of characteristics of the epidemic process in Russia.During the period from 2018 to 2020, we studied 28,395 conditionally healthy volunteers from various regions of Russia, without age and gender restrictions. Blood serum samples were tested for anti-TBE virus IgG antibodies. All volunteers completed questionnaires to collect demographic data, information about residence, TBE vaccination, and tick bites.Our study included participants from non-endemic (Moscow and the Republic of Dagestan) and endemic regions (Moscow Region, St. Petersburg, Leningrad Region, Novosibirsk Region, Khabarovsk Region). In regions with the highest protection against TBE, such as Novosibirsk Region and Khabarovsk Region, the proportions of individuals with seropositive and protective antibody titers were below 45% and 35%, respectively. The lowest rate of protective immunity was found among children (25.4% in Novosibirsk Region and 22% in Khabarovsk Region) and those aged 60 and older (27.3% and 25.1%, respectively). Situation was even more challenging in St. Petersburg and Leningrad Region, where the rate of protective antibody titers ranged from 4.3% to 8.7%. The highest vaccination coverage was found among volunteers from Novosibirsk Region and Khabarovsk Region: 32.5% and 27.4%. In St. Petersburg and Leningrad Region, vaccination coverage was ranged from 10.4% to 11.3%, while in other regions it was below 6%. The rates of post-vaccine protective immunity were 63.1% in Khabarovsk Region, 71.6% in Novosibirsk Region and up to 50% in other regions. The rates of post-infection immunity were 33.4% in Novosibirsk Region, 42.4% in Khabarovsk Region and below 12% in other regions.Our results demonstrated diversity of population immunity level and structure in different regions of Russia. The analysis showed that study participants are at risk of TBE infection, especially high in endemic regions, due to insufficient level of population immunity, vaccination coverage, and protective post-vaccine immunity.

Keywords: anti-TBEV antibodies, seroepidemiology, Prevalence, Immunological surveillance, Serological monitoring, Vaccines, Russian Federation

Received: 09 Nov 2024; Accepted: 23 Jul 2025.

Copyright: © 2025 Muminov, Gushchin, Kleymenov, Tkachuk, Manuilov, Siniavin, Ogarkova, Kuznetsova, Zlobin and Gintsburg. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Vladimir Alexeevich Gushchin, N.F.Gamaleya Scientific Research Institute of Epidemiology and Microbiology, Russian Academy of Medical Sciences, Moscow, Russia

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.